Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hearing loss: An unmet need in oncology care.

Journal of geriatric oncology·2026

Same author

Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV.

JAMA network open·2026

Same author

Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries.

JAMA network open·2026

Same author

Racial and ethnic disparities in GLP-1 prescriptions among veterans with obesity across direct and community care settings.

Health affairs scholar·2026

Same author

Chronic Conditions and Mortality in Medicare Beneficiaries Before and After the COVID-19 Pandemic.

JAMA network open·2026

Same author

Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV.

JAMA network open·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Mental status changes after hematopoietic stem cell transplantation.

Grace Chang¹, Mary-Ellen Meadows, E John Orav

¹Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA. gchang@partners.org

|June 25, 2009

Summary

Hematopoietic stem cell transplantation (HSCT) survivors experienced memory improvements over 18 months. While HSCT showed favorable mental health outcomes compared to other treatments, some physical and motor coordination deficits were noted.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jun 22, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Area of Science:

Neuroscience
Oncology
Hematology

Background:

Cancer survivors, particularly after hematopoietic stem cell transplantation (HSCT), frequently report cognitive impairments.
This study addresses the need to evaluate neurocognitive changes in patients with chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS) post-treatment.

Purpose of the Study:

To evaluate and compare neurocognitive changes in patients with CML or MDS after allogeneic HSCT versus other therapies.
To assess changes in attention, concentration, memory, mood, and quality of life over 18 months post-treatment.

Main Methods:

A prospective cohort study involving 106 patients with CML or MDS.
Serial neurocognitive and quality of life assessments were conducted at baseline, 12 months, and 18 months post-treatment.
Comparison between patients undergoing HSCT and those receiving alternative therapies.

Main Results:

Significant memory improvement was observed in all patients over 18 months.
HSCT recipients showed comparable or better neuropsychological function than other treatment groups, with notable improvements in mental health.
HSCT patients experienced worse physical function and more bilateral coordination/fine motor speed difficulties compared to other groups.

Conclusions:

Time and specific cancer diagnosis are critical factors in assessing neurocognitive and other post-treatment changes.
Cognitive deficits, sometimes attributed to 'chemobrain,' may precede treatment and potentially improve over time.
HSCT appears to be a favorable treatment option when considering mental status side effects compared to alternatives.